Vaccination Awareness in Adults with MS
A survey of 204 adults with multiple sclerosis (MS) showed high COVID-19 vaccination uptake (72.5%) but low rates for influenza (30.9%) and other vaccines (<10%). Participants expressed significant concerns about viral infections and the effects of disease-modifying treatments (DMTs) on susceptibility to infections. Awareness of Epstein-Barr virus (EBV) and its possible link to MS was notably low.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Limited
- Outcome
- Not reported
Why it matters
These findings highlight a critical gap in vaccine uptake and awareness of viral infection risks among individuals with MS, suggesting the need for better education and support to improve vaccination rates and address misconceptions.
What this does not prove
The study points out limited awareness regarding EBV and significant hesitancy toward vaccines, indicating gaps in patient education and counseling.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 204 · basis not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-12
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Adults with MS, mean age 35.7 years, primarily aged 25-44 years
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidencePerception of virus effects and vaccination among people with multiple sclerosis in Saudi Arabia. ↗DOI: 10.3389/fneur.2026.1816182
Supporting passages (10)
study designcross-sectional survey was conducted among adults with MS (n = 204) recruited using non-probability (convenience) sampling from tertiary-care clinical and community-based sources.
subjectsadults with MS (n = 204)
sample sizeMETHODS: A cross-sectional survey was conducted among adults with MS (n = 204) recruited using non-probability (convenience) sampling from tertiary-care clinical and community-based sources.
populationRESULTS: The cohort was relatively young (mean age 35.7 years), with two-thirds aged 25-44 years (25-34 years: 38.2%; 35-44 years: 36.8%).
findingsCOVID-19 vaccination uptake was high (72.5%), whereas influenza vaccination was low (30.9%).
publication datePublication date: 2026-10-12
limitationsTitle: Perception of virus effects and vaccination among people with multiple sclerosis in Saudi Arabia.
peer reviewedPublication types: Journal Article
subjectsMeSH terms: Humans; Saudi Arabia; Male; Adult; Cross-Sectional Studies; Female; Multiple Sclerosis; Vaccination; Health Knowledge, Attitudes, Practice; Middle Aged; Vaccination Hesitancy; Virus Diseases; Surveys and Questionnaires
study designMeSH terms: Humans; Saudi Arabia; Male; Adult; Cross-Sectional Studies; Female; Multiple Sclerosis; Vaccination; Health Knowledge, Attitudes, Practice; Middle Aged; Vaccination Hesitancy; Virus Diseases; Surveys and Questionnaires
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.